1. Taraxastane-type triterpenoids from the medicinal and edible plant Cirsium setosum
- Author
-
Peng-Cheng Lin, Jin-Jie Li, Xiang-Jian Zhong, Xin Wang, Sheng Lin, Xiao-Ya Shang, and Lin-Lin Ji
- Subjects
Cell Survival ,Cirsium ,Ether ,01 natural sciences ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Triterpenoid ,Cell Line, Tumor ,Drug Discovery ,Animals ,Humans ,Secretion ,Cytotoxicity ,IC50 ,Plants, Medicinal ,Molecular Structure ,biology ,Traditional medicine ,Plant Extracts ,Tumor Necrosis Factor-alpha ,010405 organic chemistry ,Chemistry ,Macrophages ,General Medicine ,biology.organism_classification ,Selective cytotoxicity ,Triterpenes ,0104 chemical sciences ,Complementary and alternative medicine ,Cell culture ,030220 oncology & carcinogenesis ,Tumor necrosis factor alpha ,Plants, Edible - Abstract
Guided by TNF-α secretion inhibitory activity assay, four taraxastane-type triterpenoids, including two new ones, 22-oxo-20-taraxasten-3β, 30-diol (1) and 22α-hydroxy-20-taraxasten-30β, 30-triol (2), have been obtained from an active fraction of the petroleum ether-soluble extract of the the medicinal and edible plant Cirsium setosum. Their structures were elucidated by spectroscopic data and CD data analysis. In the TNF-α secretion inhibitory activity assay, compounds 1 and 2 were active with the IC50 of 2.6 and 3.8 μmol·L-1, respectively. In addition, compounds 1 and 2 showed moderately selective cytotoxicity against the human ovarian cancer (A2780) and colon cancer (HCT-8) cell lines.
- Published
- 2019
- Full Text
- View/download PDF